BioLife Solutions Announces Additional Delay In Filing Of Annual Report On Form 10-K
BioLife Solutions, Inc. (NASDAQ:BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies
BioLife Solutions Q4 Sales $37.30M Beat $35.81M Estimate
BioLife Solutions (NASDAQ:BLFS) reported quarterly sales of $37.30 million which beat the analyst consensus estimate of $35.81 million by 4.17 percent. This is a 153.32 percent increase over sales of $14.73 million the
Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell
• Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 505 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 147 companies achieved new lows for the year.
BioLife Solutions Collaborates With Seattle Children’s To Improve Viral Vector And Cell Gene Therapy Manufacturing
BioLife Solutions, Inc. (NASDAQ:BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets, today announced an extended collaboration with
BioLife Solutions Q3 EPS $(0.19) Misses $(0.09) Estimate, Adj. EBITDA Loss $2.1M, Sales $33.80M Beat $31.61M Estimate
BioLife Solutions (NASDAQ:BLFS) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.09) by 111.11 percent. This is a 850 percent decrease over losses of $(0.02) per share
Earnings Scheduled For November 11, 2021
Companies Reporting Before The Bell
• NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million.